Gladys N Nangami
Overview
Explore the profile of Gladys N Nangami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Korolkova O, Widatalla S, Whalen D, Nangami G, Abimbola A, Williams S, et al.
PLoS One
. 2020 Apr;
15(4):e0231711.
PMID: 32298357
Actively growing tumors are often histologically associated with Ki67 positivity, while the detection of invasiveness relies on non-quantitative pathologic evaluation of mostly advanced tumors. We recently reported that reduced expression...
2.
Nangami G, Sakwe A, Izban M, Rana T, Lammers P, Thomas P, et al.
Cancer Med
. 2016 Nov;
5(12):3532-3543.
PMID: 27882696
Glioblastomas (high-grade astrocytomas) are highly aggressive brain tumors with poor prognosis and limited treatment options. In the present studies, we have defined the role of fetuin-A, a liver-derived multifunctional serum...
3.
Goodson 3rd W, Lowe L, Carpenter D, Gilbertson M, Ali A, Lopez de Cerain Salsamendi A, et al.
Carcinogenesis
. 2015 Jun;
36 Suppl 1:S254-96.
PMID: 26106142
Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide, but credible estimates from the World Health Organization and the International Agency for Research on Cancer (IARC) suggest...
4.
Ochieng J, Nangami G, Ogunkua O, Miousse I, Koturbash I, Odero-Marah V, et al.
Carcinogenesis
. 2015 Jun;
36 Suppl 1:S128-59.
PMID: 26106135
The purpose of this review is to stimulate new ideas regarding low-dose environmental mixtures and carcinogens and their potential to promote invasion and metastasis. Whereas a number of chapters in...
5.
Koumangoye R, Nangami G, Thompson P, Agboto V, Ochieng J, Sakwe A
Mol Cancer
. 2013 Dec;
12(1):167.
PMID: 24354805
Background: The expression of annexin A6 (AnxA6) in AnxA6-deficient non-invasive tumor cells has been shown to terminate epidermal growth factor receptor (EGFR) activation and downstream signaling. However, as a scaffolding...
6.
Nangami G, Watson K, Parker-Johnson K, Okereke K, Sakwe A, Thompson P, et al.
Biochem Biophys Res Commun
. 2013 Aug;
438(4):660-5.
PMID: 23933250
The present study was conducted to determine whether fetuin-A, a dominant serum protein plays a role in chemo-attraction and chemo-invasion of carcinoma cells in vitro. Serum is normally used as...
7.
Johnke R, Edwards J, Evans M, Nangami G, Bakken N, Kilburn J, et al.
In Vivo
. 2009 Sep;
23(5):827-33.
PMID: 19779119
Background: The purpose of this study was to investigate the immunological impact of combining neoadjuvant total androgen suppression (TAS) with radiotherapy (xRT) in the treatment of prostate cancer by monitoring...
8.
Johnke R, Smith E, Cariveau M, Evans M, Kilburn J, Bakken N, et al.
Anticancer Res
. 2009 Feb;
28(6A):3601-7.
PMID: 19189640
Background: Interleukin-1alpha (IL-1) is known to radioprotect the gastrointestinal tract, but the mechanism by which this protection occurs remains unclear. These studies were undertaken to investigate whether the radioprotective potential...